SAVELLA

Generic: MILNACIPRAN HYDROCHLORIDE

AllerganManufacturer
ORALRoute
MILNACIPRAN HYDROCHLORIDEActive Substance
2009-01-14Original Approval

SAVELLA is FDA application NDA022256, sponsored by ABBVIE. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Top Reported Reactions

1
DRUG INEFFECTIVE
94 reports
2
VOMITING
91 reports
3
PAIN
86 reports
4
HYPOAESTHESIA
85 reports
5
MEMORY IMPAIRMENT
82 reports
6
ABDOMINAL PAIN UPPER
81 reports
7
PARAESTHESIA
79 reports
8
BLEPHAROSPASM
77 reports
9
DRUG INTOLERANCE
77 reports
10
EPILEPSY
77 reports